Thomas E Mayer
Overview
Explore the profile of Thomas E Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Steinbach R, Prell T, Gaur N, Roediger A, Gaser C, Mayer T, et al.
Neuroimage Clin
. 2021 Apr;
30:102674.
PMID: 33901988
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that is characterized by a high heterogeneity in patients' disease course. Patients with bulbar onset of symptoms (b-ALS) have a poorer...
12.
Steinbach R, Gaur N, Roediger A, Mayer T, Witte O, Prell T, et al.
Hum Brain Mapp
. 2020 Oct;
42(3):737-752.
PMID: 33103324
Numerous neuroimaging studies in amyotrophic lateral sclerosis (ALS) have reported links between structural changes and clinical data; however phenotypic and disease course heterogeneity have occluded robust associations. The present study...
13.
Jochmann E, Steinbach R, Jochmann T, Chung H, Rodiger A, Neumann R, et al.
Ther Adv Neurol Disord
. 2020 Mar;
13:1756286420907803.
PMID: 32180828
Background: The antisense oligonucleotide Nusinersen recently became the first approved drug against spinal muscular atrophy (SMA). It was approved for all ages, albeit the clinical trials were conducted exclusively on...
14.
Steinbach R, Batyrbekova M, Gaur N, Voss A, Stubendorff B, Mayer T, et al.
Neuroimage Clin
. 2020 Jan;
25:102094.
PMID: 31896467
Therapeutic management and research in Amyotrophic Laterals Sclerosis (ALS) have been limited by the substantial heterogeneity in progression and anatomical spread that are endemic of the disease. Neuroimaging biomarkers represent...
15.
Besteher B, Chung H, Mayer T, Witte O, Kirchhof K, Schwab M
Clin Neuroradiol
. 2019 Nov;
30(3):629-631.
PMID: 31679044
No abstract available.
16.
Schubert J, Witte O, Settmacher U, Mayer T, Gunther A, Zanow J, et al.
Vasc Endovascular Surg
. 2018 Oct;
53(1):21-27.
PMID: 30301430
Ischemic stroke due to an acute occlusion of the extracranial internal carotid artery (eICA) is associated with high morbidity and mortality. The best treatment option remains unclear. This study aims...
17.
18.
van den Berg R, Mayer T
Interv Neuroradiol
. 2015 Oct;
21(6):646-52.
PMID: 26464291
A web-based survey was performed among the members of the World Federation of Interventional and Therapeutic Neuroradiology to determine the differences in availability, pricing, and performance of endovascular devices with...
19.
Fesl G, Holtmannspoetter M, Patzig M, Mayer T, Pfefferkorn T, Brueckmann H, et al.
Cardiovasc Intervent Radiol
. 2014 Jan;
37(2):355-61.
PMID: 24452317
Purpose: Multiple endovascular devices have been used for mechanical thrombectomy (MT) in basilar artery occlusion (BAO) for >10 years. Based on a single-center experience during the course of one decade,...
20.
Dumais K, Bredewold R, Mayer T, Veenema A
Horm Behav
. 2013 Sep;
64(4):693-701.
PMID: 24055336
Social interest reflects the motivation to approach a conspecific for the assessment of social cues and is measured in rats by the amount of time spent investigating conspecifics. Virgin female...